Sansert Patient, Information, Instructions - Methysergide maleate

Sansert Patient, Information, Instructions - Methysergide maleate

PATIENT INFORMATION

Sansert^® (methysergide maleate) is intended for use as a preventive agent in the treatment of vascular headaches. It should not be used for acute migraine attacks. If, after a 3-week trial period, Sansert^® (methysergide maleate) has not been effective in decreasing the frequency or intensity of headaches, it is unlikely that longer administration of Sansert^® (methysergide maleate) will be beneficial.

Patients should be advised to report the following symptoms immediately and to discontinue the drug: cold, numb, and painful hands and feet; leg cramps on walking; any type of girdle, flank, or chest pain; shortness of breath; or any associated symptomatology. There must be a drug-free interval of 3-4 weeks after each 6-month course of treatment.

Sansert^® (methysergide maleate) should be taken with meals. Weight gain may necessitate modification of diet.

Please also refer to the WARNINGS and PRECAUTIONS sections.